31502In view of reduced inflation and expenses, will it be right to invest in IT stocks?

With the ongoing pandemic circumstances going in the country, India’s leading vaccine manufacturer, Bharat Biotech also announced to reduce the price of its vaccine, Covaxin from Rs 600 to Rs  400 for state governments. The earlier price of the vaccine was  Rs 600 per dose for state governments. However, the prices remain the same for private hospitals at Rs 1,200 per dose.

This announcement comes a day after, Serum Institute of India had also reduced the price of Covishield vaccine for States to Rs. 300 per dose.

As per the statement issued by Bharat Biotech, they have reduced the price to Rs. 400 for state governments after recognizing the enormous challenges faced by the public healthcare system in India.

The statement also said that the manufacturer is committed to transparency and quality in terms of vaccine production, distribution, and pricing.

Covaxin is India’s indigenous COVID-19 vaccine by Bharat Biotech. It is developed in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).

Yesterday, the CEO of Serum Institute of India, another indigenous vaccine manufacturer, had also tweeted that their company has taken a philanthropic decision to reduce the price of Covishield for states to Rs 300 dose with effect, immediately.